Cargando…
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease
BACKGROUND: Current studies suggest mitochondrial dysfunction is a major contributor to impaired physical performance and exercise intolerance in chronic kidney disease (CKD). We conducted a clinical trial of coenzyme Q10 (CoQ10) and nicotinamide riboside (NR) to determine their impact on exercise t...
Autores principales: | Ahmadi, Armin, Begue, Gwenaelle, Valencia, Ana P., Norman, Jennifer E., Lidgard, Benjamin, Bennett, Brian J., Van Doren, Matthew P., Marcinek, David J., Fan, Sili, Prince, David K., Gamboa, Jorge, Himmelfarb, Jonathan, de Boer, Ian H., Kestenbaum, Bryan R., Roshanravan, Baback |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393227/ https://www.ncbi.nlm.nih.gov/pubmed/37159264 http://dx.doi.org/10.1172/jci.insight.167274 |
Ejemplares similares
-
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017) -
Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022) -
Dihydronicotinamide riboside: synthesis from nicotinamide riboside chloride, purification and stability studies
por: Zarei, Amin, et al.
Publicado: (2021) -
The Clinical Effects of Nicotinamide Riboside on Inflammatory Parameters
por: Kwon, Jun, et al.
Publicado: (2022) -
Emerging Role of Nicotinamide Riboside in Health and Diseases
por: Sharma, Chiranjeev, et al.
Publicado: (2022)